MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ijs.12581

Медицинская библиотека · International journal of stroke : official journal of the International Stroke Society · 2015

Individual patient data meta-analysis of antiplatelet regimens after noncardioembolic stroke or TIA: rationale and design.

Greving Jacoba P, Diener Hans-Christoph, Csiba László, Hacke Werner, Kappelle L Jaap, Koudstaal Peter J, Leys Didier, Mas Jean-Louis, Sacco Ralph L, Sivenius Juhani, Algra Ale, Cerebrovascular Antiplatelet Trialists' Collaborative Group

СтатьяМетаанализПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The Cerebrovascular Antiplatelet Trialists' Collaborative Group was formed to obtain and analyze individual patient data from the major randomized trials of common antiplatelet regimens after cerebral ischemia. Although the risk of stroke can be reduced by antiplatelet drugs, there continues to be uncertainty about the balance of risk and benefits of different antiplatelet regimens for an individual patient.

AIMS: Our aim is to provide clinicians with a thorough evidence-based answer on these therapeutic alternatives.

METHODS

We have identified six large randomized trials and plan to meta-analyze the data on an individual patient level. In total, these trials have enrolled 46 948 patients with cerebral ischemia. Uniquely, the Cerebrovascular Antiplatelet Trialists' Collaborative Group has secured access to the individual data of all of these trials, with the participation of key investigators and pharmaceutical companies. Our principal objective includes deriving a reliable estimate of the efficacy of different antiplatelet regimens on key outcomes including serious vascular events, major ischemic events, major bleeding, and intracranial hemorrhage.

RESULTS

We propose to redefine composite outcome events, if necessary, to achieve comparability. Further, we aim to build and validate prognostic models for the risk of major bleeding and intracranial hemorrhage and to build a decision model that may support evidence-based decision making about which antiplatelet regimen would be most effective in different risk groups of patients.

CONCLUSIONS

This paper outlines inclusion criteria, outcome measures, baseline characteristics, and planned statistical analysis.

Для цитирования: Greving Jacoba P, Diener Hans-Christoph, Csiba László, Hacke Werner, Kappelle L Jaap, Koudstaal Peter J, Leys Didier, Mas Jean-Louis, Sacco Ralph L, Sivenius Juhani, Algra Ale, Cerebrovascular Antiplatelet Trialists' Collaborative Group. Individual patient data meta-analysis of antiplatelet regimens after noncardioembolic stroke or TIA: rationale and design.. International journal of stroke : official journal of the International Stroke Society. 2015. DOI: 10.1111/ijs.12581.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.